In HNSCC, SLC3A2/CD98 were described to mark tumor stem cell populations [64] and to confer a negative prognosis, which was completely restricted to HPV-positive tumors in one report [65] but primarily described for HPV-negative tumors in others [58,66,67,68]. This evidence concerns the gene SLC3A2 and neoplasm.